Back to Results

Phreesia Inc (PHR)

Featured in High-Growth Small-Cap Stocks Small-Cap Stocks

Phreesia, Inc. is a healthcare technology company listed on the NYSE under the ticker PHR. The company provides a SaaS-based software and payments platform for healthcare organizations in the United States and Canada. Its products support appointment optimization, referral management, patient communications through AI-enabled voice and messaging tools, digital intake, clinical data capture, patient engagement, measurement and analytics, and integrated payment and financing workflows. Phreesia also offers self-service intake tablets and on-site kiosks to help manage patient check-in processes. The company serves ambulatory practices, health systems, hospitals, life sciences companies, government entities, patient advocacy groups, and other not-for-profit organizations. Phreesia was incorporated in 2005 and is based in Wilmington, Delaware.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-PHR
$14.33
36.2% Upside
Undervalued
$13.94
32.5% Upside
Undervalued
Good
—
—
—
0.0%
September 9, 2026
71.1x
1.8x
1.3x
660.2 M
670.6 M
12.3%
80.8%
0.1
—
827.4%
Send a message
Valuation • Fair Value

Phreesia Inc (NYSE-PHR) Fair Value by Valuation Model

Compare the primary fair value estimate for Phreesia Inc (NYSE-PHR) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$14.33

Estimated upside of 36.2% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$17.32

Discounted cash flow valuation reference.

Ben Graham Formula Value

$1.65

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$9.37

Earnings power value estimate.

Comps Fair Value

$12.66

Comparable-company valuation reference.

Analyst Price Target

$13.94

Analysts imply upside of 32.5%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Phreesia Inc (NYSE-PHR) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Phreesia Inc (NYSE-PHR)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

495.6 M

Current operating scale indicator.

Revenue Forecast

515 M

Forward revenue estimate.

EBITDA

32.827 M

Current operating profitability reference.

EBITDA Forecast

129.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Phreesia Inc (NYSE-PHR) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Phreesia Inc (NYSE-PHR)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.74

No elevated caution signal from this screen.

Altman Z-Score

0.1

Lower score that deserves closer risk review.

FCF / Net Income

827.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Phreesia Inc (NYSE-PHR). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Phreesia Inc (NYSE-PHR)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

September 9, 2026

Days to Earnings

50

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Phreesia Inc (NYSE-PHR), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Phreesia Inc (NYSE-PHR) Stock Forecast & Technical Outlook

Review Phreesia Inc (NYSE-PHR) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Phreesia Inc (NYSE-PHR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Phreesia Inc (NYSE-PHR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Phreesia Inc (NYSE-PHR) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Phreesia Inc (NYSE-PHR) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Phreesia Inc (NYSE-PHR) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Phreesia Inc (NYSE-PHR)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Phreesia Inc (NYSE-PHR) has a Buy consensus, with 8 buy, 8 hold and 0 sell recommendations in the current data set.

Buy 8
Hold 8
Sell 0
FAQ • Fast Investor Answers

Phreesia Inc (NYSE-PHR) Stock FAQ

Quick answers about Phreesia Inc (NYSE-PHR) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$14.33
Estimated upside 36.2%
Valuation Rating
Undervalued
Estimated upside of 36.2%
Analyst Target
$13.94
Implied upside 32.5%
Financial Health
Good
Current financial-health read

The current fair value estimate for Phreesia Inc (NYSE-PHR) is $14.33. This implies an estimated upside of 36.2% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 36.2% versus the current market price.

The available analyst price target for Phreesia Inc (NYSE-PHR) is $13.94. The analyst target implies estimated upside of 32.5%.

The current financial health read for Phreesia Inc (NYSE-PHR) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Phreesia Inc (NYSE-PHR) is September 9, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Phreesia Inc (NYSE-PHR) is 71.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Phreesia Inc is 660.2 M.

The current enterprise value listed for Phreesia Inc is 670.6 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Phreesia Inc is NYSE-PHR, and the stock is listed on NYSE.

Phreesia Inc (NYSE-PHR) is listed on NYSE.

The current debt-to-total-capital ratio listed for Phreesia Inc is 12.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Phreesia Inc is 80.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Health Care Technology Stocks on NYSE View more

Veeva Systems Inc Class A (VEEV) Veeva Systems Inc Class A (VEEV)
Doximity Inc (DOCS) Doximity Inc (DOCS)
Teladoc Inc (TDOC) Teladoc Inc (TDOC)
Evolent Health Inc (EVH) Evolent Health Inc (EVH)
Claritev Corp (CTEV) Claritev Corp (CTEV)
American Well Corp (AMWL) American Well Corp (AMWL)